This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Timmermans, C. Search for Related Content PubMed PubMed Citation Articles by Timmermans, C.

Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes

Carl Timmermans, MD^*, Samuel Lévy, MD, FACC, Gregory M. Ayers, MD, FACC, Werner Jung, MD, Luc Jordaens, MD^||, Marten Rosenqvist, MD^¶, Bernard Thibault, MD^#, John Camm, MD, FACC^**, Luz-Maria Rodriguez, MD^*, Hein J. J. Wellens, MD, FACC^* for the Metrix Investigators

^* Academic Hospital, Maastricht, the Netherlands
Hôpital Nord, Marseille, France
InControl, Inc., Redmond, Washington, USA
University of Bonn, Bonn, Germany
^|| University Hospital, Gent, Belgium
^¶ Karolinska Hospital, Stockholm, Sweden
^# Montreal Heart Institute, Quebec, Canada
^** St. George’s Hospital, London, United Kingdom

View larger version (15K): [in a new window]   Figure 1 There was an increase of the mean interval between treated spontaneous AF episodes as time since implantation of the Atrioverter increased. Solid line = observed mean and standard error of the interval between treated spontaneous AF episodes; dashed line = predicted mean of the interval between treated spontaneous AF episodes.

View larger version (16K): [in a new window]   Figure 2 Logarithmic function between the risk of a treated spontaneous AF episode and the time since implantation of the Atrioverter. As time since implantation increased, the risk of a treated spontaneous AF episode decreased.